Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0. This appears to be a minor site maintenance update with no changes to study content or user interactions.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows a minor system revision update from v3.4.0 to v3.4.1; there are no changes to core content, trial details, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedNew revision label 'Revision: v3.3.4' appears, replacing the previous 'Revision: v3.3.3'. This is a minor update that does not affect the study details or outcomes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now includes a dedicated Locations section with the Texas site information and updates the page revision to v3.3.3. The old 'Texas Locations' label and the previous revision v3.3.2 have been removed.SummaryDifference0.2%

- Check92 days agoChange DetectedPublication sourcing language was updated to explain that PubMed publications are automatically filled and may not pertain to the study. The revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.